Aclaris Therapeutics, Inc. (ACRS) Gross profit 2017–2025
Aclaris Therapeutics, Inc. (ACRS) annual gross profit history from SEC filings — each fiscal year as reported.
$5.7MFY2025 · since FY2017: $476,000 → $5.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.7M | -64.0% |
| FY2024 | $15.9M | -42.8% |
| FY2023 | $27.8M | +8.2% |
| FY2022 | $25.7M | +1156.3% |
| FY2021 | $2.0M | +51.8% |
| FY2020 | $1.3M | +684.3% |
| FY2019 | $172,000 | -94.7% |
| FY2018 | $3.2M | +580.9% |
| FY2017 | $476,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice